The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids ...

The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...